Tag: Bluebird Bio sale
FDA Turbulence Impacts Bluebird Bio Sale and Biotech VCs
Reporting on the FDA amidst the early and turbulent weeks of the Trump administration has been a rollercoaster of drama and upheaval. The recent...
BREAKING NEWS
Next-Gen Obesity Drug Disappoints: Novo Nordisk Shares Drop
Novo Nordisk, a pharmaceutical giant, recently experienced a setback that sent shockwaves through the industry. The company's highly anticipated next-generation obesity drug, CagriSema, failed...
